What it is: A synthetic heptapeptide derived from tuftsin, an immune peptide, developed in Russia and studied for anxiety reduction and cognitive enhancement without sedation.
Research suggests: Russian clinical studies report anxiolytic effects comparable to benzodiazepines with a notably different safety profile - no sedation, dependence, or withdrawal reported.
Best for: Anxiety and cognitive performance researchers
Key thing to know: Approved as an anxiolytic in Russia; independent large-scale trials outside Russia are essentially absent, which limits the evidence generalizability.
What is Selank?
Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its sequence is based on tuftsin, a naturally occurring tetrapeptide fragment of immunoglobulin G, extended with an additional tripeptide sequence to improve metabolic stability and CNS bioavailability. The resulting compound has been studied primarily for its anxiolytic and nootropic properties.
Unlike benzodiazepines, which act mainly through GABA-A receptor positive allosteric modulation, Selank is thought to engage several neurochemical systems at once. It is approved in Russia and Ukraine as an anxiolytic for generalized anxiety disorder and neurasthenia. Outside those countries it remains an unapproved research compound with no regulatory status in the US, EU, or UK.
How Selank Works
In research, the proposed mechanism has several parts.
Anxiolytic action: Selank's anxiolytic effects likely involve GABAergic modulation — enhancing GABA-A receptor sensitivity and upregulating GABA transaminase, the enzyme that breaks down GABA. This shifts the inhibitory/excitatory balance in a calming direction without fully activating the receptor as benzodiazepines do. That may explain why Selank does not appear to produce tolerance, dependence, or significant sedation in the research literature.
In rodent studies: In rodent studies, Selank upregulates brain-derived neurotrophic factor (BDNF) in the hippocampus — an effect linked to stress resilience, memory consolidation, and synaptic plasticity. It also appears to modulate serotonin transporter gene (SLC6A4) expression and influence the enkephalin system, endogenous opioid peptides involved in mood and stress regulation.
Immunomodulation: Immunomodulatory effects have also been reported, with Selank influencing interleukin-6 expression and T-helper cell activity. The compound's tuftsin ancestry may account for some of this immune-regulatory profile, though the relevance to human anxiety treatment is not yet well characterized.
What Does the Evidence Show?
The research evidence breaks down as follows.
Russian clinical trials: Multiple controlled trials at Russian institutions have evaluated Selank in patients with generalized anxiety disorder and mixed anxiety-depressive disorder. They generally report significant reductions in anxiety scores (Hamilton Anxiety Rating Scale) versus placebo, some showing efficacy comparable to low-dose benzodiazepines. The evidence is real, but nearly all studies come from one national research ecosystem, limiting independent replication.
Preclinical data: Preclinical studies in rodents consistently show increased hippocampal BDNF expression following Selank administration. BDNF upregulation is associated with antidepressant-like behavioral changes and enhanced learning in preclinical studies. Whether this translates meaningfully to human cognitive enhancement outside of an anxiety context is not yet established in independent research.
The evidence gap: Selank is widely discussed in nootropic communities for cognitive enhancement beyond anxiety relief. The research here is substantially thinner, primarily preclinical studies and anecdotal reports. Claims of improved memory, focus, and mental clarity in healthy individuals have not been rigorously tested in controlled human trials.
Relevant Labs to Review
If you are working with a healthcare provider to evaluate whether Selank might be relevant to your research goals, these are the biomarkers most commonly considered in the context of anxiety, stress response, and neurological health.
Commonly Researched Alongside Selank
Some researchers have explored Selank in combination with other compounds targeting overlapping or complementary pathways. These pairings are based on published research and observed mechanisms, not clinical recommendations.
Research Connections
Explore the Full Peptide Library
Browse research profiles for peptides across recovery, cognitive health, metabolic support, and longevity, all in one place.